“…GS39783 is an in vivo effective, positive allosteric modulator (PAM) of the GABA B receptor (GABA B PAM) (Urwyler et al, 2003). During recent years, several behavioral studies have depicted an interesting pharmacological profile for GS39783: its acute or repeated administration (a) exerted anxiolytic-like effects in some rat and mouse models of anxiety (Cryan et al, 2004; Mombereau et al, 2004; see, however, Paterson & Hanania, 2010; Sweeney, O’Leary, & Cryan, 2013), and (b) suppressed several alcohol-related behaviors, including alcohol drinking in sP rats exposed to the 2-bottle “alcohol vs. water” choice regimen with unlimited access (Orrù et al, 2005) and operant, oral alcohol self-administration in alcohol-preferring sP, Indiana P, and Alko Alcohol (AA) rats (Maccioni et al, 2007, 2008, 2010, 2012, 2015). Notably, with regard to the aims of the present study, a recent investigation (Linsenbardt & Boehm, 2014) found that acute treatment with GS39783 suppressed binge-like drinking in C57BL/6J mice exposed to the “Drinking-in-the-Dark” procedure (i.e., daily exposure to a single alcohol bottle in daily 2- or 4-h drinking sessions, occurring early in the dark phase [see Thiele & Navarro, 2014]).…”